IXA - Amsterdam Neuroscience was founded in 2013 with the goal to extend and intensify the collaboration between industry and academic research groups within Amsterdam Neuroscience. Since 2013 IXA - Amsterdam Neuroscience has enabled access to scientific excellence, platform technologies, brain imaging infrastructure, and patient cohorts and material.
This is always based on a disease-orientated approach: Neurodegeneration (AD, FTD, Lewy Body Dementia and Vascular Cognitive Impairment), Neuro-inflammation (MS), Neuro-infection (Meningitis, Chronic Inflammatory Demyelinating Polyneuropathy), Neurovascular Disorders and Neuropsychiatry (Anxiety and Depression, Psychosis, OCD, PTSD and SZ). We have a track record of clinical trials and translational research projects with over 120 companies.
![Infographic describing the position of the Industry Alliance Office](/upload_mm/5/4/6/32333_fullimage_infographic_iao_web2_768x432.jpg)
Meet the IXA - Amsterdam Neuroscience team on our people page